SCHEMBL7213666

SCHEMBL7213666

N#CC1=Cc2ccc(O)cc2OC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESRRB O95718 7/20 0.42
ESRRA P11474 7/20 0.42
TYR P14679 1/20 0.39
CYP3A4 P08684 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
APP P05067 1/20 0.36
MAPKAPK2 P49137 1/20 0.33
MIF P14174 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 1/20 0.33
CA2 P00918 1/20 0.33
CA5A P35218 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
RARA P10276 1/20 0.32
RARG P13631 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34471543 0.80 HTR2C (0.31)
SCHEMBL20839736 0.80 MMP12 (0.35) ALDH1A1MAPTRAB9ALMNA
SCHEMBL28127083 0.77 CYP3A4 (0.45) TYRCYP3A4NR1H4ESR1ESR2
SCHEMBL30939479 0.77 CYP3A4 (0.45) TYRCYP3A4NR1H4ESR1ESR2
SCHEMBL430257 0.76 ALOX5 (0.51) CYP3A4NR1H4ALDH1A1MAPTRAB9A
SCHEMBL432893 0.75 ALOX5 (0.41) ALDH1A1MAPTRAB9ACA2MAOA
SCHEMBL4430663 0.73 TYR (0.54) TYRCYP3A4NR1H4ALDH1A1MAPT
Idronoxil SCHEMBL149612 0.72 ESR2 (0.49) TYRCYP3A4NR1H4ESR1ESR2
Idronoxil SCHEMBL29353213 0.72 ESR2 (0.49) TYRCYP3A4NR1H4ESR1ESR2
SCHEMBL20722762 0.71 ALDH1A1 (0.36) ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653340-B1 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway BIOCRYST PHARMACEUTICALS, INC. 2003-11-25 US disclosed
EP-1066272-A4 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARM INC (US) 2002-03-13 EP disclosed
EP-1066272-A1 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARMACEUTICALS INC. (US) 2001-01-10 EP disclosed
WO-1998055471-A1 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARMACEUTICALS, INC. (US) 1998-12-10 WO disclosed